glp-1 loss of muscle mass GLP-1's and Why preserving muscle matters while

Develop alternative coping mechanisms before the food coping mechanism disappears

Moreover, in subjects with diabetes who were at high risk of cardiovascular events, treatment with GLP-1R agonists based on the structure of endogenous GLP-1, namely liraglutide, semaglutide, albiglutide, and dulaglutide, has demonstrated reductions in major adverse cardiovascular events (MACEs) that appear to be unrelated to the glycemic effects of these agents (1316)

Paradoxically, improved blood glucose control often reduces urination frequency

doi: 10.1097/ADM.0000000000001347 30

Individual results vary based on numerous factors including age, baseline health, dietary habits, activity level, and consistency of use